Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc S Ernstoff

Showing results (31-40 of 169) with videos related to

Pageof 17
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|March 11, 2021
A Rapid Exosome Isolation Using Ultrafiltration and Size Exclusion Chromatography (REIUS) Method for Exosome Isolation from Melanoma Cell LinesShin La Shu, Cheryl L Allen, Shawna Benjamin-Davalos, et al.
Oncology Letters|October 19, 2013
Merkel cell polyomavirus and extrapulmonary small cell carcinomaKathryn C Hourdequin, Joel A Lefferts, Jeoffry B Brennick, et al.
International Journal of Cancer|March 12, 2005
Pigmentary characteristics and moles in relation to melanoma riskLinda Titus-Ernstoff, Ann E Perry, Steven K Spencer, et al.
Immunotherapy|February 18, 2020
Impact of concomitant medication use and immune-related adverse events on response to immune checkpoint inhibitorsShipra Gandhi, Manu Pandey, Nischala Ammannagari, et al.
Archives of Dermatology|April 19, 2006
Multiple primary melanoma: two-year results from a population-based studyLinda Titus-Ernstoff, Ann E Perry, Steven K Spencer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2006
Docetaxel, estramustine, and 15-month androgen deprivation for men with prostate-specific antigen progression after definitive local therapy for prostate cancerMary-Ellen Taplin, Wanling Xie, Glenn J Bubley, et al.
Transfusion|January 23, 2014
The natural killer-activating receptor, NKG2D, on CD3+CD8+ T cells plays a critical role in identifying and killing autologous myeloma cellsLaleh Talebian, Dawn A Fischer, Jillian Wu, et al.
Cancer|August 16, 2006
A phase II study of gemcitabine and capecitabine in metastatic renal cancer: a report of Cancer and Leukemia Group B protocol 90008Walter M Stadler, Susan Halabi, Brian Rini, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 15, 2012
Adoptive cellular therapy using cells enriched for NKG2D+CD3+CD8+T cells after autologous transplantation for myelomaKenneth R Meehan, Laleh Talebian, Tor D Tosteson, et al.
Cytotherapy|September 30, 2010
Immune mobilization of autologous blood progenitor cells: direct influence on the cellular subsets collectedKenneth R Meehan, Laleh Talebian, Jillian Wu, et al.
Pageof 17

Showing results (31-40 of 169) with videos related to

Sort By:
Pageof 17
Methods in Molecular Biology (Clifton, N.J.)|March 11, 2021
A Rapid Exosome Isolation Using Ultrafiltration and Size Exclusion Chromatography (REIUS) Method for Exosome Isolation from Melanoma Cell LinesShin La Shu, Cheryl L Allen, Shawna Benjamin-Davalos, et al.
Oncology Letters|October 19, 2013
Merkel cell polyomavirus and extrapulmonary small cell carcinomaKathryn C Hourdequin, Joel A Lefferts, Jeoffry B Brennick, et al.
International Journal of Cancer|March 12, 2005
Pigmentary characteristics and moles in relation to melanoma riskLinda Titus-Ernstoff, Ann E Perry, Steven K Spencer, et al.
Immunotherapy|February 18, 2020
Impact of concomitant medication use and immune-related adverse events on response to immune checkpoint inhibitorsShipra Gandhi, Manu Pandey, Nischala Ammannagari, et al.
Archives of Dermatology|April 19, 2006
Multiple primary melanoma: two-year results from a population-based studyLinda Titus-Ernstoff, Ann E Perry, Steven K Spencer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2006
Docetaxel, estramustine, and 15-month androgen deprivation for men with prostate-specific antigen progression after definitive local therapy for prostate cancerMary-Ellen Taplin, Wanling Xie, Glenn J Bubley, et al.
Transfusion|January 23, 2014
The natural killer-activating receptor, NKG2D, on CD3+CD8+ T cells plays a critical role in identifying and killing autologous myeloma cellsLaleh Talebian, Dawn A Fischer, Jillian Wu, et al.
Cancer|August 16, 2006
A phase II study of gemcitabine and capecitabine in metastatic renal cancer: a report of Cancer and Leukemia Group B protocol 90008Walter M Stadler, Susan Halabi, Brian Rini, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 15, 2012
Adoptive cellular therapy using cells enriched for NKG2D+CD3+CD8+T cells after autologous transplantation for myelomaKenneth R Meehan, Laleh Talebian, Tor D Tosteson, et al.
Cytotherapy|September 30, 2010
Immune mobilization of autologous blood progenitor cells: direct influence on the cellular subsets collectedKenneth R Meehan, Laleh Talebian, Jillian Wu, et al.
Pageof 17